中国微创外科杂志
中國微創外科雜誌
중국미창외과잡지
CHINESE JOURNAL OF MINIMALLY INVASIVE SURGERY
2014年
9期
786-791
,共6页
王艳%李宝华%李立%常耀文%苏东君%王文辉%李奋强
王豔%李寶華%李立%常耀文%囌東君%王文輝%李奮彊
왕염%리보화%리립%상요문%소동군%왕문휘%리강강
重症急性胰腺炎%超早期肠内营养%肠外营养%数字减影血管造影
重癥急性胰腺炎%超早期腸內營養%腸外營養%數字減影血管造影
중증급성이선염%초조기장내영양%장외영양%수자감영혈관조영
Severe acute pancreatitis ( SAP)%Super early enteral nutrition%Parenteral nutrition%Digital substraction angiography(DSA)
目的:探讨DSA引导下经鼻肠营养管超早期肠内营养在重症急性胰腺炎( severe acute pancreatitis , SAP)治疗中的有效性和安全性。方法回顾分析我院2008年6月~2011年3月120例符合SAP诊断标准的临床资料,其中60例入院24 h之内给予DSA引导下经鼻肠营养管植入(超早期肠内营养组),60例禁食期间未行任何方式的肠内营养支持治疗(完全胃肠外营养组)。比较2组患者住院时间、住院费用、病死率、入院前后的APACHE Ⅱ评分、Ranson评分,治疗14 d后血、尿淀粉酶、血清白蛋白及血清前白蛋白等。结果超早期肠内营养组总住院时间(41.5±21.1) d,明显短于完全胃肠外营养组(58.9±26.7)d(t=-3.369,P=0.001);住院费用(67416.9±22659.5)元,明显少于完全胃肠外营养组(383592.5±92493.5)元(t=-25.718,P=0.000);腹腔感染率6.7%(4/60),显著低于完全胃肠外营养组25.0%(15/60)(χ2=7.566, P=0.006);院内感染率26.7%(16/60),显著低于全胃肠外营养组56.7%(34/60)(χ2=11.109,P=0.001)。2组患者治疗前后的血淀粉酶、尿淀粉酶、C-反应蛋白、血清前白蛋白、APACHE Ⅱ评分、Ranson评分均有显著性差异( P<0.05);2组治疗后血、尿淀粉酶、血清前白蛋白、血清白蛋白和C-反应蛋白降幅有统计学差异( t=16.968,P=0.000;t=35.348,P=0.000;t=20.072,P=0.000;t=-22.359,P=0.000;t=-2.234,P=0.027),但2组治疗后APACHE Ⅱ评分、Ranson评分无统计学差异( P>0.05)。结论与完全胃肠外营养组相比,超早期肠内营养在SAP治疗中安全、有效,无严重并发症,同时具有营养丰富、费用低等优点。
目的:探討DSA引導下經鼻腸營養管超早期腸內營養在重癥急性胰腺炎( severe acute pancreatitis , SAP)治療中的有效性和安全性。方法迴顧分析我院2008年6月~2011年3月120例符閤SAP診斷標準的臨床資料,其中60例入院24 h之內給予DSA引導下經鼻腸營養管植入(超早期腸內營養組),60例禁食期間未行任何方式的腸內營養支持治療(完全胃腸外營養組)。比較2組患者住院時間、住院費用、病死率、入院前後的APACHE Ⅱ評分、Ranson評分,治療14 d後血、尿澱粉酶、血清白蛋白及血清前白蛋白等。結果超早期腸內營養組總住院時間(41.5±21.1) d,明顯短于完全胃腸外營養組(58.9±26.7)d(t=-3.369,P=0.001);住院費用(67416.9±22659.5)元,明顯少于完全胃腸外營養組(383592.5±92493.5)元(t=-25.718,P=0.000);腹腔感染率6.7%(4/60),顯著低于完全胃腸外營養組25.0%(15/60)(χ2=7.566, P=0.006);院內感染率26.7%(16/60),顯著低于全胃腸外營養組56.7%(34/60)(χ2=11.109,P=0.001)。2組患者治療前後的血澱粉酶、尿澱粉酶、C-反應蛋白、血清前白蛋白、APACHE Ⅱ評分、Ranson評分均有顯著性差異( P<0.05);2組治療後血、尿澱粉酶、血清前白蛋白、血清白蛋白和C-反應蛋白降幅有統計學差異( t=16.968,P=0.000;t=35.348,P=0.000;t=20.072,P=0.000;t=-22.359,P=0.000;t=-2.234,P=0.027),但2組治療後APACHE Ⅱ評分、Ranson評分無統計學差異( P>0.05)。結論與完全胃腸外營養組相比,超早期腸內營養在SAP治療中安全、有效,無嚴重併髮癥,同時具有營養豐富、費用低等優點。
목적:탐토DSA인도하경비장영양관초조기장내영양재중증급성이선염( severe acute pancreatitis , SAP)치료중적유효성화안전성。방법회고분석아원2008년6월~2011년3월120례부합SAP진단표준적림상자료,기중60례입원24 h지내급여DSA인도하경비장영양관식입(초조기장내영양조),60례금식기간미행임하방식적장내영양지지치료(완전위장외영양조)。비교2조환자주원시간、주원비용、병사솔、입원전후적APACHE Ⅱ평분、Ranson평분,치료14 d후혈、뇨정분매、혈청백단백급혈청전백단백등。결과초조기장내영양조총주원시간(41.5±21.1) d,명현단우완전위장외영양조(58.9±26.7)d(t=-3.369,P=0.001);주원비용(67416.9±22659.5)원,명현소우완전위장외영양조(383592.5±92493.5)원(t=-25.718,P=0.000);복강감염솔6.7%(4/60),현저저우완전위장외영양조25.0%(15/60)(χ2=7.566, P=0.006);원내감염솔26.7%(16/60),현저저우전위장외영양조56.7%(34/60)(χ2=11.109,P=0.001)。2조환자치료전후적혈정분매、뇨정분매、C-반응단백、혈청전백단백、APACHE Ⅱ평분、Ranson평분균유현저성차이( P<0.05);2조치료후혈、뇨정분매、혈청전백단백、혈청백단백화C-반응단백강폭유통계학차이( t=16.968,P=0.000;t=35.348,P=0.000;t=20.072,P=0.000;t=-22.359,P=0.000;t=-2.234,P=0.027),단2조치료후APACHE Ⅱ평분、Ranson평분무통계학차이( P>0.05)。결론여완전위장외영양조상비,초조기장내영양재SAP치료중안전、유효,무엄중병발증,동시구유영양봉부、비용저등우점。
Objective To explore the effectiveness and the safety of super early enteral nutrition (SEEN) in the treatment of severe acute pancreatitis (SAP). Methods Clinical data of 120 patients diagnosed as SAP in this hospital during June 2008 to March 2011 were retrospectively reviewed .Among the 120 patients, nose intestinal feeding tube placement under the guidance of DSA within 24 hours after admission was carried out in 60 patients (super early enteral nutrition group, SEEN), while the other 60 patients did not accept the treatment of intestinal feeding tube placement ( total parenteral nutrition group , TPN) .The length of stay ,incidence of serious complications, mortality, curative effects, APACHEⅡ scores, Ranson grades,amylase levels 14 days after treatment, and serum albumin and prealbumin changes were compared between the two groups . Results The SEEN group showed shorter length of hospital stay[(41.5 ±21.1) d vs.(58.9 ±26.7) d, t=-3.369, P=0.001] and lower hospitalization expenses [(67 416.9 ± 22 659.5) yuan vs.(383 592.5 ±92 493.5) yuan, t=-25.718, P=0.000].The SEEN group had an abdominal infection rate of 6.7%(4/60) and a nosocomial infection rate of 26.7%(16/60), which were less than the TPN group [25.0% (15/60), χ2 =7.566, P=0.006;56.7%(34/60),χ2 =11.109, P=0.001].There were significant differences in serum amylase , urine amylase, C-reactive protein, serum prealbumin, APACHE Ⅱ scores, and Ranson scores before and after the treatment in both groups (P<0.05).After treatment, there were significant differences between the two groups in levels of blood amylase , urine amylase,prealbumin, serum albumin, and C-reactive protein (t =16.968,P=0.000;t =35.348,P =0.000;t =20.072,P =0.000;t=-22.359,P=0.000;t=-2.234,P=0.027).There were no obvious statistical significances in APACHE Ⅱ scores and Ranson scores between the two groups after treatment (P>0.05). Conclusion Super early enteral nutrition is a safe and effective method for SAP, bearing advantages of no serious complications , cost-effectiveness, and rich nutrition.